CVBT is committed to exploring medical applications for our drugs which contain the active pharmaceutical ingredient of FGF-1. To achieve this goal, we conduct ongoing research and continually collaborate with internationally recognized researchers in the areas of tissue regeneration, angiogenesis and growth factors.

We place a high priority on communicating information about our clinical trials to physicians, patients, investors, and other interested parties.

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2010 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.